Your brain doesn't have to age on autopilot. New research shows we can slow—and potentially reverse—brain aging.
Compared with placebo, ATH434 demonstrated a statistically significant 48% slowing of clinical progression (based on UMSARS score) at the 50mg dose at week 52. The Food and Drug Administration (FDA) ...
HONOLULU — A novel “moderate-affinity iron chaperone” known as ATH434 (Alterity Therapeutics) may slow disease progression in patients with multiple system atrophy (MSA), new research suggested. The ...
New MRI research reveals that heavy smoking can shrink key brain regions tied to memory and cognition, and excess weight might intensify the damage, raising fresh questions about dementia prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback